Effective Treatment in Fewer Sessions with Hypofractionation
60-65% of Stage I and Stage II invasive breast cancer cases, which constitute 15% of all cancers, are Stage I and Stage II invasive breast
60-65% of Stage I and Stage II invasive breast cancer cases, which constitute 15% of all cancers, are Stage I and Stage II invasive breast
Neolife’s patient-centered approach and quality have made it a trusted name in oncology abroad with the opening of six new centers in Europe.